Intravenous Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension
- 31 December 2009
- journal article
- clinical trial
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 155 (6), 841-847.e1
- https://doi.org/10.1016/j.jpeds.2009.06.012
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Population Pharmacokinetics of Sildenafil in Term Neonates: Evidence of Rapid Maturation of Metabolic Clearance in the Early Postnatal PeriodClinical Pharmacology & Therapeutics, 2008
- Hyperoxia Increases Phosphodiesterase 5 Expression and Activity in Ovine Fetal Pulmonary Artery Smooth Muscle CellsCirculation Research, 2008
- Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded StudyPublished by American Academy of Pediatrics (AAP) ,2006
- Sildenafil Citrate Therapy for Pulmonary Arterial HypertensionThe New England Journal of Medicine, 2005
- Interaction between Inhaled Nitric Oxide and Intravenous Sildenafil in a Porcine Model of Meconium Aspiration SyndromePediatric Research, 2004
- Intravenous Sildenafil Lowers Pulmonary Vascular Resistance in a Model of Neonatal Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionalityBritish Journal of Clinical Pharmacology, 2002
- Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the NewbornThe New England Journal of Medicine, 2000
- Developmental Changes in Lung cGMP Phosphodiesterase-5 Activity, Protein, and MessageAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory FailureThe New England Journal of Medicine, 1997